Want to see HK:6086 full AI Analyst Report?
6086 Stock Chart & Stats
HK$3.63
HK$0.21(4.98%)
At close: 4:00 PM EST
HK$3.63
HK$0.21(4.98%)
Day’s Range― - ―
52-Week RangeHK$0.63 - HK$5.26
Previous CloseN/A
Volume737.00K
Average Volume (3M)2.01M
Market Cap
HK$900.54M
Enterprise ValueHK$2.63K
Total Cash (Recent Filing)HK$377.52M
Total Debt (Recent Filing)HK$35.81M
Price to Earnings (P/E)64.6
Beta1.76
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,385,448,500
10 Day Avg. Volume2,214,042
30 Day Avg. Volume2,011,125
Financial Highlights & Ratios
PEG Ratio-2.25
Price to Book (P/B)17.52
Price to Sales (P/S)0.76
P/FCF Ratio41.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.03
Revenue Forecast (FY)HK$4.69B
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability TurnaroundThe return to positive operating profit and net income indicates improving operating execution and demand. If revenue growth continues, the turnaround could provide a foundation for stronger earnings, although profitability remains early-stage.
Improved Cash GenerationPositive operating and free cash flow strengthens internal funding capacity and reduces reliance on external capital. This improves business resilience, provided cash conversion becomes more consistent across future reporting periods.
Lower Leverage And Positive EquityLower leverage and positive equity provide greater flexibility to fund operations and absorb volatility. A healthier capital structure can reduce financial risk during the ongoing profitability recovery and support longer-term business continuity.
Bears Say
Very Thin Profit MarginsVery thin margins leave limited protection against cost inflation, pricing pressure, or execution setbacks. Small changes in revenue or expenses could materially affect earnings, making the profitability turnaround less durable.
Declining Gross MarginA sustained gross-margin decline can constrain operating leverage even when revenue grows. It suggests the company may face competitive pricing pressure or rising input costs, limiting the ability to convert expansion into durable profits.
Historical Balance-Sheet VolatilityPast negative equity indicates that financial stability has not yet been proven through a full operating cycle. If profitability weakens again, the company could face renewed balance-sheet pressure and reduced strategic flexibility.
Fangzhou Inc. News
6086 FAQ
What was Fangzhou Inc.’s price range in the past 12 months?
Fangzhou Inc. lowest stock price was HK$0.63 and its highest was HK$5.26 in the past 12 months.
What is Fangzhou Inc.’s market cap?
Fangzhou Inc.’s market cap is HK$900.54M.
When is Fangzhou Inc.’s upcoming earnings report date?
Fangzhou Inc.’s upcoming earnings report date is Aug 27, 2026 which is in 6 days.
How were Fangzhou Inc.’s earnings last quarter?
Fangzhou Inc. released its earnings results on Mar 19, 2026. The company reported HK$0 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Fangzhou Inc. overvalued?
According to Wall Street analysts Fangzhou Inc.’s price is currently Overvalued.
Does Fangzhou Inc. pay dividends?
Fangzhou Inc. does not currently pay dividends.
What is Fangzhou Inc.’s EPS estimate?
Fangzhou Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fangzhou Inc. have?
Fangzhou Inc. has 1,385,448,500 shares outstanding.
What happened to Fangzhou Inc.’s price movement after its last earnings report?
Fangzhou Inc. reported an EPS of HK$0 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.04%.
Which hedge fund is a major shareholder of Fangzhou Inc.?
Currently, no hedge funds are holding shares in HK:6086
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fangzhou Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-64.98%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
28.27%
Trailing 12-Months
Company Description
Fangzhou Inc.
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Technical Analysis
Dingdang Health Technology Group Ltd.
―
CANbridge Pharmaceuticals Inc.
―
Modern Chinese Medicine Group Co. Ltd.
―
Sunho Biologics,Inc.
―
Beijing Biostar Pharmaceuticals Co., Ltd. Class H
―